If liver function tests are abnormal or imaging shows an enlarged liver, fatty change, or a suspicious lesion, your doctor may recommend a liver biopsy. The word “biopsy” can sound intimidating, but understanding why it is done—and that there are multiple safe approaches—can significantly reduce anxiety.
A liver biopsy is a diagnostic procedure in which a small sample of liver tissue is obtained and examined under a microscope. It remains the gold standard for assessing fibrosis, inflammation, steatosis, cirrhosis, and malignancy. While blood tests and imaging provide valuable information, biopsy can offer histological detail that other tests cannot.
At Medanta – The Medicity, Gurugram, Dr. A.S. Soin and the hepatology team perform a high volume of liver biopsies using contemporary, safety-focused techniques. If you are considering a liver biopsy in Delhi NCR or elsewhere in India, this guide explains your options clearly.
Why Is a Liver Biopsy Recommended?
A liver biopsy is usually advised when non-invasive tests are inconclusive or when precise staging or diagnosis will change management. Common indications include:
- Persistently abnormal liver enzymes (ALT, AST, ALP, GGT) with unclear cause
- Evaluation and staging of chronic hepatitis B or C (less frequent now with non-invasive tools, but still relevant in selected cases)
- Assessment of metabolic dysfunction–associated steatotic liver disease (MASLD, previously NAFLD) and steatohepatitis (MASH)
- Unexplained cholestasis or jaundice
- Monitoring after liver transplantation (rejection, recurrent disease, drug toxicity)
- Characterization of focal liver lesions when imaging is indeterminate
- Staging fibrosis or cirrhosis when it will influence treatment decisions
- Diagnosis of less common conditions such as autoimmune hepatitis, haemochromatosis, Wilson’s disease, or drug-induced liver injury
Dr. A.S. Soin emphasizes that biopsy decisions are individualized: “We always weigh the diagnostic value against procedural risk and choose the safest, most informative approach for each patient.”
The Three Main Types of Liver Biopsy
The choice depends on coagulation status, presence of ascites, indication (diffuse disease vs focal lesion), and overall clinical condition.
1. Percutaneous Liver Biopsy — The Standard Approach
This is the most commonly used method for diffuse liver disease. A fine biopsy needle is passed through the skin into the liver, typically between the ribs.
How it is performed
The patient lies supine or slightly turned. Under local anaesthesia (often with ultrasound marking or real-time guidance), a needle is inserted into the liver to obtain a core sample. The procedure itself takes minutes; total stay is usually 4–6 hours for observation.
Who is it suitable for?
- Diffuse liver disease requiring histological assessment
- Acceptable coagulation profile (commonly INR ≤ 1.5 and platelets ≥ 50,000–60,000/µL, depending on institutional protocols)
- No or minimal ascites
- Cooperative patients able to follow breathing instructions
Advantages
- Simple, quick, and cost-effective
- Provides adequate core tissue for histology
- Often a day-care procedure
Limitations
- Not suitable in significant coagulopathy or uncontrolled anticoagulation
- Higher bleeding risk in advanced liver dysfunction
- Technically difficult in moderate to severe ascites
2. Ultrasound- or CT-Guided Liver Biopsy — Precision Sampling
These are image-guided variants of percutaneous biopsy, used when targeting a specific lesion.
Ultrasound-guided biopsy
Real-time imaging allows continuous visualization of the needle path. It is widely available, avoids radiation, and is the first choice for most focal lesions.
CT-guided biopsy
Used when lesions are small, deep, poorly visualized on ultrasound, or obscured by bowel gas or obesity. CT offers excellent anatomical detail but involves limited radiation exposure.
Who is it suitable for?
- Focal liver lesions or indeterminate nodules
- Suspected hepatocellular carcinoma (when imaging is not diagnostic) or metastases
- Cases where prior biopsy was non-diagnostic
Advantages
- High diagnostic accuracy through precise targeting
- Reduced risk of sampling error
Limitations
- Requires imaging expertise and coordination
- CT involves radiation and may take longer
At Medanta, hepatologists and interventional radiologists collaborate closely to ensure accurate lesion targeting while minimizing risk.
3. Transjugular Liver Biopsy (TJLB) — For High-Risk Patients
TJLB is preferred when bleeding risk is high. Instead of puncturing the liver from outside, the biopsy is performed from within the venous system.
How it is performed
Under local anaesthesia and sedation, a catheter is inserted into the right internal jugular vein, advanced through the superior vena cava into the hepatic vein. A სპეციal biopsy needle is passed through the catheter to obtain tissue from within the liver. Fluoroscopy guides the procedure. Hepatic venous pressure gradient (HVPG) can be measured simultaneously if needed.
Who is it suitable for?
- Significant coagulopathy or thrombocytopenia
- Moderate to large ascites
- Advanced liver disease or pre-transplant evaluation
- Need for HVPG measurement
- Obesity or technically difficult percutaneous access
Advantages
- Lower risk of clinically significant bleeding (bleeding occurs into the venous system)
- Can be performed safely in ascites
- Allows portal hypertension assessment via HVPG
Limitations
- Technically more complex; requires experienced interventional radiology team
- Smaller and sometimes fragmented tissue samples
- Limited availability in some centers
What to Expect: Before, During, and After
Before the procedure
- Blood tests: haemoglobin, platelet count, INR/PT
- Temporary discontinuation of anticoagulants/antiplatelets as advised
- Fasting for 6–8 hours
- Informed consent after discussion of risks and benefits
During the procedure
- Local anaesthesia (with or without mild sedation)
- Duration: 15–45 minutes depending on technique
- One or more core samples obtained (typically 1–2 cm in length)
After the procedure
- Observation for 4–6 hours (longer if high risk)
- Mild pain at the biopsy site or right shoulder may occur
- Avoid driving the same day
- Results usually available within 3–7 working days
Are There Risks?
Liver biopsy is generally safe when performed in experienced centers with proper patient selection.
- Bleeding: the most important complication; major bleeding occurs in <1% of cases
- Pain: usually mild and self-limiting
- Injury to adjacent organs: rare, minimized with imaging guidance
- Infection: very uncommon
- Bile leak: rare
Careful pre-procedure evaluation and appropriate technique selection significantly reduce these risks.
Liver Biopsy in India: Access and Expertise
India offers high-quality hepatology care with experienced specialists and modern infrastructure. Costs are substantially lower than in many Western countries while maintaining international standards of safety and pathology reporting.
Medanta – The Medicity in Gurugram is a major referral center for liver disease, serving patients from across India and internationally. Under the leadership of Dr. A.S. Soin, the team integrates hepatology, transplant surgery, and interventional radiology for comprehensive care.
The Bottom Line
A liver biopsy remains a powerful diagnostic tool—but choosing the right method is crucial. Percutaneous biopsy suits most patients with stable coagulation. Image-guided biopsy is ideal for focal lesions. Transjugular biopsy provides a safer alternative in high-risk situations.
An individualized, evidence-based approach ensures that the procedure is both safe and clinically meaningful—helping guide the right treatment at the right time.
If you have been advised to undergo a liver biopsy, timely evaluation and informed decision-making can make a significant difference in outcomes.
